OmicsChart

Startup

Oncology translational research teams are under pressure to provide biological evidence to support drug development. OmicsChart enables translational cancer scientists to test hypotheses and gain insights from harmonized public, proprietary and in-house biomarker data in just a few clicks. Built on federated data integration, oncology domain-driven ML/AI, with biologist-friendly scientific visualizations and a trusted research environment for bioinformaticians, our solution reduces the time required for data acquisition and analysis by 150 times compared to current practices. The platform provides insights on DNA and RNA biomarkers, immune cell composition and single-cell tumor resolution integrated with clinical information across 35 cancer types. In just the last 6 months over 10 biotech and pharma companies used our solution to strengthen their evidence and build conviction around clinical development strategy, calling our product a game-changer for translational cancer research.